Gene · 6443
Papers1,640
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,640
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of Dietary Components on Mast Cells: Possible Use as Nutraceuticals for Allergies? | Cells | 2023 | 37998337 | PubTator, text mining | PubMed |
| Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets. | Signal Transduct Target Ther | 2023 | 37981648 | PubTator, text mining | PubMed |
| Knockdown of SLC39A14 inhibits glioma progression by promoting erastin-induced ferroptosis SLC39A14 knockdown inhibits glioma progression. | BMC Cancer | 2023 | 37978473 | PubTator, text mining | PubMed |
| Clinical features, imaging findings and molecular data of limb-girdle muscular dystrophies in a cohort of Chinese patients. | Orphanet J Rare Dis | 2023 | 37974208 | PubTator, text mining | PubMed |
| The Physiological Function of nNOS-Associated CAPON Proteins and the Roles of CAPON in Diseases. | Int J Mol Sci | 2023 | 37958792 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis and Experimental Validation of SOX4 as a Potential Diagnosis, Prognosis, and Immunotherapy Biomarker. | Cancers (Basel) | 2023 | 37958409 | PubTator, text mining | PubMed |
| A novel in silico scaffold-hopping method for drug repositioning in rare and intractable diseases. | Sci Rep | 2023 | 37938624 | PubTator, text mining | PubMed |
| CCT8 promotes cell migration and tumor metastasis in lung adenocarcinomas. | J Cancer | 2023 | 37928427 | PubTator, text mining | PubMed |
| Bromodomain Factor 5 as a Target for Antileishmanial Drug Discovery. | ACS Infect Dis | 2023 | 37906637 | PubTator, text mining | PubMed |
| Novel mutations in the SGCA gene in unrelated Vietnamese patients with limb-girdle muscular dystrophies disease. | Front Genet | 2023 | 37900180 | PubTator, text mining | PubMed |
| Pharmacotherapeutic Approaches to Treatment of Muscular Dystrophies. | Biomolecules | 2023 | 37892218 | PubTator, text mining | PubMed |
| Soluble guanylyl cyclase: A novel target for the treatment of vascular cognitive impairment? | Pharmacol Res | 2023 | 37884069 | PubTator, text mining | PubMed |
| Does dietary nitrate boost the effects of caloric restriction on brain health? Potential physiological mechanisms and implications for future research. | Nutr Metab (Lond) | 2023 | 37880786 | PubTator, text mining | PubMed |
| Olanzapine alters the expression of gasotransmitter-related enzymes: CBS and HO-2 in the rat hippocampus and striatum. | Pharmacol Rep | 2023 | 37874531 | PubTator, text mining | PubMed |
| Artificial intelligence and the analysis of cryo-EM data provide structural insight into the molecular mechanisms underlying LN-lamininopathies. | Sci Rep | 2023 | 37857770 | PubTator, text mining | PubMed |
| Single-centre experience with autosomal recessive limb-girdle muscular dystrophy: case series and literature review. | Arq Neuropsiquiatr | 2023 | 37852290 | PubTator, text mining | PubMed |
| Exome Sequencing and Optical Genome Mapping in Molecularly Unsolved Cases of Duchenne Muscular Dystrophy: Identification of a Causative X-Chromosomal Inversion Disrupting the DMD Gene. | Int J Mol Sci | 2023 | 37834164 | PubTator, text mining | PubMed |
| In vivo noninvasive systemic myography of acute systemic vasoactivity in female pregnant mice. | Nat Commun | 2023 | 37813833 | PubTator, text mining | PubMed |
| Hydroxyurea does not reverse functional alterations of the nitric oxide-cGMP pathway associated with priapism phenotype in corpus cavernosum from sickle cell mouse. | PLoS One | 2023 | 37812620 | PubTator, text mining | PubMed |
| Impact of selexipag use within 12 months of pulmonary arterial hypertension diagnosis on hospitalizations and medical costs: A retrospective cohort study. | Clin Respir J | 2023 | 37804160 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6443/papers?page=8